Real Hope For Alzheimer’s Disease- ProMIS™ Neurosciences

Help for Alzheimer’s Disease.

Alzheimer’s Disease is disease that affects more than 25 million people. There is no cure, but there is new hope. Moreover, recent studies reveal new understanding of the root cause of Alzheimer’s. This has led to a major shift in research for a cure.
 
Amyloid beta theory says plaque build-up in the brain cause Alzheimer’s disease. But, we now know that the root cause of Alzheimer’s is not plaque. The toxic oligomer kills the brain cells. Furthersome, it leads to Alzheimer’s and other neurodegenerative diseases.
 
ProMIS is been dedicated to developing PMN310. Is is an effective therapy for Alzheimer’s disease. It is by targeting its root cause.
 
Also, new understanding of the amyloid beta theory could help. It delivers much needed medicine. It will reach to the millions of people affected by this terrible disease.
 
Above all, we are offering real hope for an effective Alzheimer’s disease treatment.

More about ProMIS™ Neurosciences Inc.

The headquater of ProMIS™ Neurosciences, Inc. is in Toronto Ontario. Our offices is in Cambridge Massachusetts. ProMIS is a development stage biotechnology company. Our focus is on discovering and developing antibody therapeutics. It selectively targets the toxic oligomers. It is implicated in the development and progression. In particular, Alzheimer’s disease is amyotrophic lateral sclerosis and Parkinson’s disease.

For more information on ProMIS Neurosciences Inc. (PMN:TSX) please fill out the form below.

Request Investor Kit

Name*

Email*

*Required.